250 related articles for article (PubMed ID: 17692473)
1. Intra-arterial rhenium-188 lipiodol in the treatment of inoperable hepatocellular carcinoma: results of an IAEA-sponsored multination study.
Bernal P; Raoul JL; Vidmar G; Sereegotov E; Sundram FX; Kumar A; Jeong JM; Pusuwan P; Divgi C; Zanzonico P; Stare J; Buscombe J; Minh CT; Saw MM; Chen S; Ogbac R; Padhy AK
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1448-55. PubMed ID: 17692473
[TBL] [Abstract][Full Text] [Related]
2. International Atomic Energy Agency-sponsored multination study of intra-arterial rhenium-188-labeled lipiodol in the treatment of inoperable hepatocellular carcinoma: results with special emphasis on prognostic value of dosimetric study.
Bernal P; Raoul JL; Stare J; Sereegotov E; Sundram FX; Kumar A; Jeong JM; Pusuwan P; Divgi C; Zanzonico P; Vidmar G; Buscombe J; Chau TT; Saw MM; Chen S; Ogbac R; Dondi M; Padhy AK
Semin Nucl Med; 2008 Mar; 38(2):S40-5. PubMed ID: 18243842
[TBL] [Abstract][Full Text] [Related]
3. Preliminary results of transarterial rhenium-188 HDD lipiodol in the treatment of inoperable primary hepatocellular carcinoma.
Sundram F; Chau TC; Onkhuudai P; Bernal P; Padhy AK
Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):250-7. PubMed ID: 15129708
[TBL] [Abstract][Full Text] [Related]
4. Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma.
Leung WT; Lau WY; Ho S; Chan M; Leung N; Lin J; Ho KC; Metreweli C; Johnson PJ; Li AK
J Nucl Med; 1994 Aug; 35(8):1313-8. PubMed ID: 7519259
[TBL] [Abstract][Full Text] [Related]
5. Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-lipiodol therapy in patients with hepatocellular carcinoma.
De Ruyck K; Lambert B; Bacher K; Gemmel F; De Vos F; Vral A; de Ridder L; Dierckx RA; Thierens H
J Nucl Med; 2004 Apr; 45(4):612-8. PubMed ID: 15073257
[TBL] [Abstract][Full Text] [Related]
6. Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma.
Raoul JL; Guyader D; Bretagne JF; Heautot JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M
Hepatology; 1997 Nov; 26(5):1156-61. PubMed ID: 9362356
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of high activity rhenium-188-microsphere in hepatic radioembolization.
Liepe K; Brogsitter C; Leonhard J; Wunderlich G; Hliscs R; Pinkert J; Folprecht G; Kotzerke J
Jpn J Clin Oncol; 2007 Dec; 37(12):942-50. PubMed ID: 18094017
[TBL] [Abstract][Full Text] [Related]
8. Inoperable hepatocellular carcinoma: transarterial 188Re HDD-labeled iodized oil for treatment--prospective multicenter clinical trial.
Kumar A; Srivastava DN; Chau TT; Long HD; Bal C; Chandra P; Chien le T; Hoa NV; Thulkar S; Sharma S; Tam le H; Xuan TQ; Canh NX; Pant GS; Bandopadhyaya GP
Radiology; 2007 May; 243(2):509-19. PubMed ID: 17456873
[TBL] [Abstract][Full Text] [Related]
9. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead.
Poon RT; Tso WK; Pang RW; Ng KK; Woo R; Tai KS; Fan ST
Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1100-8. PubMed ID: 17627902
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival.
Lau WY; Lai EC; Leung TW; Yu SC
Ann Surg; 2008 Jan; 247(1):43-8. PubMed ID: 18156922
[TBL] [Abstract][Full Text] [Related]
11. Intra-arterial injection of iodine-131-labeled lipiodol for treatment of hepatocellular carcinoma.
Boucher E; Garin E; Guylligomarc'h A; Olivié D; Boudjema K; Raoul JL
Radiother Oncol; 2007 Jan; 82(1):76-82. PubMed ID: 17141900
[TBL] [Abstract][Full Text] [Related]
12. Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of 131I-labelled lipiodol.
Raoul JL; Messner M; Boucher E; Bretagne JF; Campion JP; Boudjema K
Br J Surg; 2003 Nov; 90(11):1379-83. PubMed ID: 14598418
[TBL] [Abstract][Full Text] [Related]
13. 188Re-HDD/lipiodol therapy for hepatocellular carcinoma: a phase I clinical trial.
Lambert B; Bacher K; Defreyne L; Gemmel F; Van Vlierberghe H; Jeong JM; Dierckx RA; Van de Wiele C; Thierens H; De Vos F
J Nucl Med; 2005 Jan; 46(1):60-6. PubMed ID: 15632035
[TBL] [Abstract][Full Text] [Related]
14. 188Re-HDD/lipiodol for treatment of hepatocellular carcinoma: a feasibility study in patients with advanced cirrhosis.
Lambert B; Bacher K; De Keukeleire K; Smeets P; Colle I; Jeong JM; Thierens H; Troisi R; De Vos F; Van de Wiele C
J Nucl Med; 2005 Aug; 46(8):1326-32. PubMed ID: 16085590
[TBL] [Abstract][Full Text] [Related]
15. Rhenium-188 based radiopharmaceuticals for treatment of liver tumours.
Lambert B; Bacher K; Defreyne L
Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):305-10. PubMed ID: 19521309
[TBL] [Abstract][Full Text] [Related]
16. Pilot study of transarterial chemoembolization with pirarubicin and amiodarone for unresectable hepatocellular carcinoma.
Guiu B; Colin C; Cercueil JP; Loffroy R; Guiu S; Ferrant E; Jouve JL; Bonnetain F; Boulin M; Ghiringhelli F; Minello A; Hillon P; Bedenne L; Krause D; Chauffert B
Am J Clin Oncol; 2009 Jun; 32(3):238-44. PubMed ID: 19349854
[TBL] [Abstract][Full Text] [Related]
17. Intra-arterial iodine-131-lipiodol for unresectable hepatocellular carcinoma.
Chua TC; Chu F; Butler SP; Quinn RJ; Glenn D; Liauw W; Morris DL
Cancer; 2010 Sep; 116(17):4069-77. PubMed ID: 20564150
[TBL] [Abstract][Full Text] [Related]
18. A report on the implementation aspects of the International Atomic Energy Agency's first doctoral coordinated research project, "Management of liver cancer using radionuclide methods with special emphasis on trans-arterial radio-conjugate therapy and internal dosimetry".
Padhy AK; Dondi M
Semin Nucl Med; 2008 Mar; 38(2):S5-12. PubMed ID: 18243843
[TBL] [Abstract][Full Text] [Related]
19. Management of postsurgical recurrence of hepatocellular carcinoma with rhenium 188-HDD labeled iodized oil.
Kumar A; Srivastava DN; Bal C
J Vasc Interv Radiol; 2006 Jan; 17(1):157-61. PubMed ID: 16415146
[TBL] [Abstract][Full Text] [Related]
20. Treatment of unresectable hepatocellular carcinoma with radiolabelled lipiodol.
Kanhere HA; Leopardi LN; Fischer L; Kitchener MI; Maddern GJ
ANZ J Surg; 2008 May; 78(5):371-6. PubMed ID: 18380736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
